What Policy Makers Need to Know About Counterfeit Drugs in the United States

With the explosive growth of global medication counterfeiting crime rings, it is essential for policy makers across all disciplines to familiarize themselves with the counterfeit drug problem in the United States.

At Partnership for Safe Medicines, we have compiled resources based on research and news reports of counterfeit drug incidents in the United States. Policy makers can use these resources to inform themselves and their staffers about how drug counterfeiters exploit U.S. patients. Download and share the following: